FORTREA HOLDINGS INC. Earnings Per Share (Basic)
FORTREA HOLDINGS INC. (FTRE) reported Earnings Per Share (Basic) of -$0.14 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-07-29
- FORTREA HOLDINGS INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.14.
- FORTREA HOLDINGS INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.25.
- FORTREA HOLDINGS INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.17.
- FORTREA HOLDINGS INC. earnings per share, basic for the quarter ending 2025-06-30 was -$4.14.
- FORTREA HOLDINGS INC. earnings per share, basic for fiscal 2025 was -$10.81.
- FORTREA HOLDINGS INC. earnings per share, basic for fiscal 2024 was -$3.67.
- FORTREA HOLDINGS INC. earnings per share, basic for fiscal 2023 was -$0.29, a 113.88% decline from fiscal 2022.
- FORTREA HOLDINGS INC. earnings per share, basic for fiscal 2022 was $2.09, a 90.00% increase from fiscal 2021.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.14 10-Q · filed 2026-07-29 | -$0.39 10-Q · filed 2026-07-29 | ||||||
| 2026-03-31 | -$0.25 10-Q · filed 2026-05-05 | |||||||
| 2025-12-31 | -$10.81 10-K · filed 2026-02-26 | |||||||
| 2025-09-30 | -$0.17 10-Q · filed 2025-11-05 | -$10.53 10-Q · filed 2025-11-05 | ||||||
| 2025-06-30 | -$4.14 10-Q · filed 2026-07-29 | -$10.37 10-Q · filed 2026-07-29 | -$11.09 derived: net income ÷ weighted average shares · filed 2026-07-29 | -$11.41 derived: net income ÷ weighted average shares · filed 2026-07-29 | ||||
| 2025-03-31 | -$6.25 10-Q · filed 2026-05-05 | -$6.94 derived: net income ÷ weighted average shares · filed 2026-07-29 | -$7.26 derived: net income ÷ weighted average shares · filed 2026-07-29 | -$8.81 derived: net income ÷ weighted average shares · filed 2026-07-29 | ||||
| 2024-12-31 | -$0.69 derived: net income ÷ weighted average shares · filed 2026-04-27 | -$1.00 derived: net income ÷ weighted average shares · filed 2026-04-27 | -$2.54 derived: net income ÷ weighted average shares · filed 2026-04-27 | -$3.67 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$0.31 10-Q · filed 2025-11-05 | -$1.86 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$2.99 10-Q · filed 2025-11-05 | -$3.60 derived: net income ÷ weighted average shares · filed 2026-04-27 | ||||
| 2024-06-30 | -$1.55 10-Q · filed 2025-08-06 | -$2.69 10-Q · filed 2025-08-06 | -$3.30 derived: net income ÷ weighted average shares · filed 2026-04-27 | -$3.46 derived: net income ÷ weighted average shares · filed 2026-04-27 | ||||
| 2024-03-31 | -$1.13 10-Q · filed 2025-05-12 | -$1.74 derived: net income ÷ weighted average shares · filed 2026-04-27 | -$1.90 derived: net income ÷ weighted average shares · filed 2026-04-27 | -$1.56 derived: net income ÷ weighted average shares · filed 2026-04-27 | ||||
| 2023-12-31 | -$0.61 derived: net income ÷ weighted average shares · filed 2026-04-27 | -$0.77 derived: net income ÷ weighted average shares · filed 2026-04-27 | -$0.42 derived: net income ÷ weighted average shares · filed 2026-04-27 | -$0.29 10-K · filed 2026-02-26 | -$0.04 10-K · filed 2024-03-13 | |||
| 2023-09-30 | -$0.16 10-Q · filed 2024-11-08 | -$0.15 10-Q · filed 2023-11-13 | $0.19 derived: net income ÷ weighted average shares · filed 2024-11-08 | $0.33 10-Q · filed 2024-11-08 | $0.37 10-Q · filed 2023-11-13 | $0.63 derived: net income ÷ weighted average shares · filed 2025-03-03 | ||
| 2023-06-30 | $0.35 10-Q · filed 2024-08-12 | $0.32 10-Q · filed 2023-08-14 | $0.49 10-Q · filed 2024-08-12 | $0.51 10-Q · filed 2023-08-14 | $0.79 derived: net income ÷ weighted average shares · filed 2025-03-03 | $1.47 derived: net income ÷ weighted average shares · filed 2025-03-03 | ||
| 2023-03-31 | $0.14 10-Q · filed 2024-05-24 | $0.44 derived: net income ÷ weighted average shares · filed 2025-03-03 | $1.12 derived: net income ÷ weighted average shares · filed 2025-03-03 | $1.87 derived: net income ÷ weighted average shares · filed 2025-03-03 | ||||
| 2022-12-31 | $0.30 derived: net income ÷ weighted average shares · filed 2025-03-03 | $0.98 derived: net income ÷ weighted average shares · filed 2025-03-03 | $1.73 derived: net income ÷ weighted average shares · filed 2025-03-03 | $2.09 10-K · filed 2025-03-03 | $2.17 10-K · filed 2024-03-13 | |||
| 2022-09-30 | $0.68 10-Q · filed 2023-11-13 | $1.43 derived: net income ÷ weighted average shares · filed 2023-11-13 | $1.80 10-Q · filed 2023-11-13 | |||||
| 2022-06-30 | $0.75 10-Q · filed 2023-08-14 | $1.11 10-Q · filed 2023-08-14 | ||||||
| 2021-12-31 | $1.10 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |